Cargando…
Metabolic profiling reveals metabolic features of consolidation therapy in pediatric acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) and its treatment continue to pose substantial risks. To understand ALL more deeply, the metabolome in fasting plasma of 27 ALL patients before and after high-dose methotrexate therapies (consolidation therapy) including methotrexate and 6-mercaptopurine (6-MP) was...
Autores principales: | Fu, Jinqiu, Zhang, Aijun, Liu, Qinqin, Li, Dong, Wang, Xiaoming, Si, Libo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869545/ https://www.ncbi.nlm.nih.gov/pubmed/36691092 http://dx.doi.org/10.1186/s40170-023-00302-6 |
Ejemplares similares
-
Dasatinib-associated chylothorax in a pediatric patient with chronic myeloid leukemia: a case report and literature review
por: Liu, Qinqin, et al.
Publicado: (2023) -
Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment
por: Kotur, Nikola, et al.
Publicado: (2020) -
Distinct N7-methylguanosine profiles of circular RNAs in drug-resistant acute myeloid leukemia
por: Fu, Jinqiu, et al.
Publicado: (2023) -
Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020) -
Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone
por: Warris, Lidewij T., et al.
Publicado: (2016)